Congenital Disorders of Glycosylation

November 11, 2022

The Congenital Disorders of Glycosylation session will be discussing overview of CDG and potential/existing treatments.

Commercial Supporter 

This educational activity is supported by an educational grant from Ultragenyx.

Learning Objectives

  • Describe clinical features and presentations of the 170 types of congenital disorders of glycoslyation (CDG). 
  • List and access key CDG resources available to healthcare professionals, patients and families, including support organizations and clinical guidelines. 
  • Identify current therapies and emerging clinical trials for CDG.  

 

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
10/10/2022
Course expires: 
11/25/2022
Event starts: 
11/11/2022 - 12:00pm MST
Event ends: 
11/11/2022 - 1:30pm MST
Cost:
$0.00
Rating: 
0

Guest Faculty

 

Hudson Freeze, MD
Sanford Burnham Prebys Medical Discovery Institute


 

Disclosures

Hudson Freeze, MD, speaker for this session, is a consultant for GlycoMIne, BridgeBio and Avalo Therapeutics. 

Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.

All of the relevant financial relationships listed have been mitigated. 

Medical

Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Children’s Hospital Colorado designates this Live activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Others

A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance

Price

Cost:
$0.00
Please login or register to take this course.